Chen Allen M, Granchi Phillip J, Garcia Joaquin, Bucci M Kara, Fu Karen K, Eisele David W
Department of Radiation Oncology, University of California, San Francisco (UCSF) Comprehensive Cancer Center, San Francisco, CA 94143, USA.
Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):982-7. doi: 10.1016/j.ijrobp.2006.10.043. Epub 2007 Jan 22.
To determine factors predictive of local-regional recurrence (LRR) after surgery alone for carcinomas of the major salivary glands in an attempt to evaluate the potential role of postoperative radiation therapy.
Between 1960 and 2004, 207 patients with carcinomas of the major salivary glands were treated with definitive surgery without postoperative radiation therapy. Histology was: 67 mucoepidermoid (32%), 50 adenoid cystic (24%), 34 acinic cell (16%), 23 malignant mixed (11%), 16 adenocarcinoma (8%), 6 oncocytic (3%), 6 myoepithelial (3%), and 5 other (2%). Distribution of pathologic T-stage was: 54 T1 (26%), 83 T2 (40%), 46 T3 (22%), and 24 T4 (12%). Sixty patients (29%) had microscopically positive margins. Median follow-up was 6.1 years (range, 0.5-18.7 years).
The 5-year and 10-year estimates of local-regional control were 86% and 74%, respectively. A Cox proportional hazard model identified pathologic lymph node metastasis (hazard ratio [HR], 4.8; p = 0.001), high histologic grade (HR, 4.2; p = 0.003), positive margins (HR, 2.6; p = 0.03), and T3-4 disease (HR, 2.0; p = 0.04) as independent predictors of LRR. The presence of any one of these factors was associated with 10-year local-regional control rates of 37% to 63%.
Lymph node metastasis, high tumor grade, positive margins, and T3-4 stage predict for significant rates of LRR after surgery for carcinomas of the major salivary glands. Postoperative radiation therapy should be considered for patients with these disease characteristics.
确定单纯手术治疗大唾液腺癌后局部区域复发(LRR)的预测因素,以评估术后放疗的潜在作用。
1960年至2004年间,207例大唾液腺癌患者接受了根治性手术,未进行术后放疗。组织学类型为:黏液表皮样癌67例(32%),腺样囊性癌50例(24%),腺泡细胞癌34例(16%),恶性混合瘤23例(11%),腺癌16例(8%),嗜酸性细胞癌6例(3%),肌上皮癌6例(3%),其他5例(2%)。病理T分期分布为:T1期54例(26%),T